The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy.
Authors:
- Meredith L. WallaceMWMeredith L. Wallace
- Jay C. FournierJFJay C. Fournier
- Paola RucciPRPaola Rucci
- Ellen FrankEFEllen Frank
- 1 January 2012
- journal article
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 80 (5) , 719-729
Abstract
Depressed patients with comorbid personality pathology may fare worse in treatment for depression than those without this additional pathology, and comorbid personality pathology may be associated with superior response in one form of treatment relative to another, though recent findings have been mixed. We aimed to evaluate the effect of personality pathology on time to remission of patients randomly assigned to 1 of 2 treatment strategies for depression and to determine whether personality pathology moderated the effect of treatment assignment on outcome. Individuals undergoing an episode of unipolar major depression (n = 275) received interpersonal psychotherapy (Klerman, Weissman, Rounsaville, & Chevron, 1984) or selective serotonin reuptake inhibitor (SSRI) pharmacotherapy for depression. Depressive symptoms were measured with the HRSD-17. Remission was a mean HRSD-17 score of 7 or below over a period of 3 weeks. Personality disorders were measured according to SCID-II diagnoses, and personality pathology was measured dimensionally by summing the positive probes on the SCID-II. The presence of at least 1 personality disorder was not a significant predictor of time to remission, but a higher level of dimensionally measured personality pathology and the presence of borderline personality disorder were associated with a longer time to remission. Personality pathology did not moderate the effect of treatment assignment on time to remission. The findings suggest that depressed individuals with comorbid personality pathology generally fare worse in treatment for depression, although in this report, the effect of personality pathology did not differ by the type of treatment received.Keywords
This publication has 36 references indexed in Scilit:
- Personality Disorder Types Proposed for DSM-5Journal of Personality Disorders, 2011
- Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapyPsychological Medicine, 2010
- Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combinationJournal of Affective Disorders, 2009
- Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depressionClinical Trials, 2008
- Antidepressant medicationsv.cognitive therapy in people with depression with or without personality disorderThe British Journal of Psychiatry, 2008
- Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introductionInternational Journal of Methods in Psychiatric Research, 2007
- Efficacy of pharmacotherapy in depressed patients with and without personality disorders: A systematic review and meta-analysisJournal of Affective Disorders, 2005
- Clinical Outcome of ECT in Patients With Major Depression and Comorbid Borderline Personality DisorderAmerican Journal of Psychiatry, 2004
- Personality pathology and outcome in recurrently depressed women over 2 years of maintenance interpersonal psychotherapyPsychological Medicine, 2004
- The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: Empirical findings from the Treatment for Depression Collaborative Research Program.Journal of Consulting and Clinical Psychology, 1996